{"id":"https://openalex.org/W4400108964","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6570","title":"A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure.","display_name":"A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4400108964","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6570"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.6570","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6570","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.6570","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.6570","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.6570","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028622482","display_name":"Kelly Sharon Chien","orcid":"https://orcid.org/0000-0001-6024-1613","observed_orcids":["https://orcid.org/0000-0001-6024-1613"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly Sharon Chien","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030063957","display_name":"Juan Jos\u00e9 Rodr\u00edguez\u2010Sevilla","orcid":"https://orcid.org/0000-0002-4741-7925","observed_orcids":["https://orcid.org/0000-0002-4741-7925"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan Jose Rodriguez-Sevilla","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036627133","display_name":"Yesid Alvarado Valero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yesid Alvarado Valero","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028081179","display_name":"Guillermo Montalban Bravo","orcid":"https://orcid.org/0000-0002-4533-5176","observed_orcids":["https://orcid.org/0000-0002-4533-5176"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Montalban Bravo","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085006230","display_name":"Danielle E. Hammond","orcid":"https://orcid.org/0000-0002-6017-2264","observed_orcids":["https://orcid.org/0000-0002-6017-2264"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Hammond","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050673025","display_name":"Mahesh Swaminathan","orcid":"https://orcid.org/0000-0001-5959-397X","observed_orcids":["https://orcid.org/0000-0001-5959-397X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mahesh Swaminathan","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060548911","display_name":"Alexandre Bazinet","orcid":"https://orcid.org/0000-0001-5538-4943","observed_orcids":["https://orcid.org/0000-0001-5538-4943"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Bazinet","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099633957","display_name":"Jacqueline Kimberley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline Kimberley","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109350294","display_name":"Kristy R. Bodden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristy Bodden","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020300580","display_name":"Heather Schneider","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Schneider","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102375926","display_name":"Xiao Qin Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiao Qin Dong","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030500582","display_name":"Sherry A. Pierce","orcid":"https://orcid.org/0000-0002-9542-1558","observed_orcids":["https://orcid.org/0000-0002-9542-1558"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherry Pierce","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057822243","display_name":"Xuelin Huang","orcid":"https://orcid.org/0000-0003-1192-9336","observed_orcids":["https://orcid.org/0000-0003-1192-9336"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xuelin Huang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elias Jabbour","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"6570","last_page":"6570"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mcl-1-inhibitors","display_name":"Mcl-1 inhibitors","score":0.8700000047683716},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7329999804496765},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7369999885559082},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.7099999785423279},{"id":"https://openalex.org/keywords/adverse-cardiac-events","display_name":"adverse cardiac events","score":0.7379999756813049},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.3619999885559082},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.5210000276565552},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4269999861717224},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.49000000953674316},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.47600001096725464},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.5070000290870667},{"id":"https://openalex.org/keywords/stem-cell-transplantation","display_name":"stem cell transplantation","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9309991002082825},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6564206480979919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6441925168037415},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.5841764211654663},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5818837285041809},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5639190673828125},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.556640625},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5204641819000244},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47537532448768616},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.43482428789138794},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3478648364543915},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.22355347871780396},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.6570","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6570","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.6570","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.6570","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.6570","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6570","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.6570","pdf_url":"https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.6570","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400108964.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2048281482","https://openalex.org/W2013806387","https://openalex.org/W2060228790","https://openalex.org/W2189342016","https://openalex.org/W2001929837","https://openalex.org/W2042704711","https://openalex.org/W2167485228","https://openalex.org/W4286817035","https://openalex.org/W1575781057","https://openalex.org/W4388951914"],"abstract_inverted_index":{"6570":[0],"Background:":[1],"Though":[2,394],"hypomethylating":[3],"agent":[4],"(HMA)":[5],"therapy":[6,27],"is":[7],"standard":[8,114],"for":[9,47,357],"patients":[10],"(pts)":[11],"with":[12,72,93,128,162,307,325,378,426],"myelodysplastic":[13],"syndromes":[14],"(MDS),":[15],"once":[16],"pts":[17,71,92,121,143,150,239,253,300,322,339,377,396,399],"are":[18],"refractory":[19],"to":[20,25,214,229,247,260,265,267,280,282,294],"or":[21,103,428],"no":[22,261,395],"longer":[23],"respond":[24],"HMA":[26,29,73,94,101,381,427],"(i.e.":[28],"failure),":[30],"survival":[31],"remains":[32],"dismal":[33],"and":[34,67,86,148,159,200,241,286,350,370,387,404,414,417],"treatment":[35],"options":[36],"non-existent.":[37],"Tapotoclax":[38],"directly":[39],"induces":[40],"apoptosis":[41],"in":[42,58,70,134,372,424],"cells":[43,328],"dependent":[44],"on":[45,108],"MCL1":[46,53],"survival.":[48],"Given":[49,409],"preclinical":[50],"data":[51],"establishing":[52],"as":[54],"a":[55,79,113,163,373],"promising":[56],"target":[57],"MDS,":[59],"we":[60],"hypothesized":[61],"that":[62,210,366],"tapotoclax":[63,89,124,145,176,215,230,367,423],"may":[64,431],"be":[65],"safe":[66,369],"clinically":[68],"active":[69],"failure":[74,95],"MDS.":[75],"Methods:":[76],"We":[77],"designed":[78],"phase":[80,362],"I":[81],"study":[82,258,364],"evaluating":[83],"the":[84,135,304,331,420],"safety":[85],"tolerability":[87],"of":[88,165,168,173,175,249,298,333,376,422],"(NCT05209152).":[90],"Adult":[91],"MDS":[96,379],"(no":[97],"response":[98],"after":[99,318,380],"\u22654":[100],"cycles":[102,174],"progression/relapse":[104],"at":[105,330],"any":[106],"time":[107,332],"HMAs)":[109],"were":[110,154,184,193,211,236,255,323,385],"eligible.":[111],"Using":[112],"modified":[115],"Toxicity":[116],"Probability":[117],"Interval":[118],"design,":[119],"all":[120],"received":[122,144,177],"intravenous":[123],"every":[125],"7":[126,358],"days":[127,133],"each":[129],"cycle":[130,319,348],"lasting":[131],"28":[132],"exploratory":[136],"dose-finding":[137],"portion.":[138],"Results:":[139],"Between":[140],"10/2022-12/2023,":[141],"4":[142,166],"120":[146],"mg/m2":[147],"3":[149,299],"240":[151],"mg/m2.":[152],"Pts":[153],"overall":[155],"very":[156],"high":[157],"risk":[158],"heavily":[160],"pre-treated":[161],"median":[164,171],"lines":[167],"therapy.":[169],"The":[170,186],"number":[172],"was":[178,244,368],"3.":[179,320],"No":[180,232,238,383],"dose-limiting":[181],"toxicities":[182],"(DLTs)":[183],"observed.":[185,237],"most":[187],"common":[188],"treatment-related":[189],"adverse":[190],"events":[191],"(AEs)":[192],"nausea":[194],"(85%),":[195],"fatigue":[196],"(43%),":[197],"diarrhea":[198],"(29%),":[199],"palpitations":[201],"(14%).":[202],"Regarding":[203],"cardiac":[204,388],"AEs,":[205],"1":[206,263,271,277,287,351,363],"pt":[207,219],"experienced":[208,400],"arrhythmias":[209],"possibly":[212],"related":[213],"but":[216,224,314,337],"self-resolved.":[217],"One":[218],"had":[220,225],"prolonged":[221],"QTc":[222],"intervals":[223],"similar":[226],"prolongation":[227],"prior":[228],"exposure.":[231],"clinically-significant":[233],"troponin":[234],"elevations":[235],"responded,":[240,397],"this":[242],"trial":[243,306,335,436],"terminated":[245],"due":[246,259,279,293],"lack":[248],"clinical":[250,305,334],"activity.":[251],"Three":[252],"(43%)":[254],"taken":[256],"off":[257],"response,":[262],"(14%)":[264,272,278,288,353],"proceed":[266],"stem":[268],"cell":[269],"transplantation,":[270],"from":[273,289],"recurrent":[274],"peritoneal":[275],"cancer,":[276],"transformation":[281],"acute":[283],"myeloid":[284],"leukemia,":[285],"an":[290],"unrelated":[291],"death":[292],"infection.":[295],"However,":[296],"2":[297],"(67%)":[301],"who":[302],"started":[303],"BM":[308],"blasts":[309],"\u2265":[310],"5%":[311],"underwent":[312],"transient":[313,401],"unsustained":[315],"blast":[316,402],"reduction":[317,403],"All":[321],"transfusion-dependent":[324],"red":[326],"blood":[327],"(RBCs)":[329],"enrollment,":[336],"5":[338],"(71%)":[340],"decreased":[341,405],"RBC":[342,406],"transfusions":[343],"by":[344],"\u22652":[345],"units":[346],"between":[347],"1-2":[349],"individual":[352],"attained":[354],"transfusion":[355,407],"independence":[356],"weeks.":[359],"Conclusions:":[360],"This":[361],"demonstrated":[365],"tolerated":[371],"high-risk":[374],"cohort":[375],"failure.":[382],"DLTs":[384],"observed,":[386],"AEs":[389],"self-resolved":[390],"without":[391],"dose":[392],"reductions.":[393],"some":[398],"burden.":[408],"its":[410],"manageable":[411],"toxicity":[412],"profile":[413],"transitory":[415],"anti-leukemic":[416],"transfusion-independent":[418],"effects,":[419],"use":[421],"combination":[425],"other":[429],"therapies":[430],"warrant":[432],"further":[433],"consideration.":[434],"Clinical":[435],"information:":[437],"NCT05209152":[438],".":[439]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}